Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments
Kirstin I Oliveira Roster1, Minttu M Rönn2, Eva R Gorenburg3
1Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Abstract:
Numerous factors may influence the optimal rollout of new gonococcal antibiotics. We compared 8 rollout strategies using a gonorrhea transmission model and ranked strategies by the number of gonococcal infections and clinically useful antibiotic lifespan. Rankings were most sensitive to the starting ceftriaxone resistance prevalence and screening frequency.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial DNA Synthesis
Development of Antibiotic Resistance
Urine Studies II: Urine Culture and Sensitivity Test
Trichomoniasis

